Intracellular effect of imidazoline receptor on α2A-noradrenergic receptor

被引:8
作者
Chen, MJ
Zhu, H
Piletz, JE
机构
[1] Univ Mississippi, Med Ctr, Dept Psychiat, Jackson, MS 39216 USA
[2] Calif State Univ Los Angeles, Los Angeles, CA 90032 USA
[3] Jackson State Univ, Jackson, MS 39217 USA
来源
AGMATINE AND IMIDAZOLINES: THEIR NOVEL RECEPTORS AND ENZYMES | 2003年 / 1009卷
关键词
imidazoline receptors; alpha(2) adrenoceptor; IRAS; Nischarin; coincidence detection;
D O I
10.1196/annals.1304.057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Imidazoline-1 receptors (I1R) and alpha(2)-noradrenergic receptors (alpha(2)AR) are known to coexist in many cell types and bind many of the same imidazoline ligands. Herein, the possibility of an interaction between these receptors was explored using a cloned cDNA that encodes a protein with I1R-like binding properties, designated imidazoline receptor antisera-selected (IRAS). Chinese hamster ovary (CHO) sublines permanently expressing the human subtype alpha(2A)AR cDNA were transiently cotransfected with the human IRAS cDNA (pIRAS). Saturation radioligand binding experiments on membranes isolated from the various sublines allowed distinction between I1R and alpha(2A)AR. Transfection of pIRAS into either subline led to a rise in membrane I1R-binding sites. Immunoblotting revealed that IRAS was enriched in membranes more than in cytosolic fractions. Transfection of pIRAS in CHO cells harboring the alpha(2A)AR cDNA resulted in a twofold increase in alpha(2A)AR binding sites with no change in alpha(2A)AR binding affinity, compared with controls. Immunoblotting also revealed increased expression of membranous alpha(2A)AR by IRAS. Thus, pIRAS transfection led to I-1 binding sites and to an increase in alpha(2A)AR binding sites in CHO cells expressing the human alpha(2A)AR. Although the mechanism is unclear, this increase in binding sites may explain previous imidazoline drug effects suggestive of interactions between these two receptors.
引用
收藏
页码:427 / 438
页数:12
相关论文
共 47 条
[1]   Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice [J].
Altman, JD ;
Trendelenburg, AU ;
Macmillan, L ;
Bernstein, D ;
Limbird, L ;
Starke, K ;
Kobilka, BK ;
Hein, L .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :154-161
[2]   NEW CONCEPTS ON THE CENTRAL REGULATION OF BLOOD-PRESSURE - ALPHA-2-ADRENOCEPTORS AND IMIDAZOLINE RECEPTORS [J].
BOUSQUET, P ;
FELDMAN, J ;
TIBIRICA, E ;
BRICCA, G ;
MOLINES, A ;
DONTENWILL, M ;
BELCOURT, A .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (3C) :S10-S13
[3]   Respective contributions of α-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs [J].
Bruban, V ;
Feldman, J ;
Greney, H ;
Dontenwill, M ;
Schann, S ;
Jarry, C ;
Payard, M ;
Boutin, J ;
Scalbert, E ;
Pfeiffer, B ;
Renard, P ;
Vanhoutte, P ;
Bousquet, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (02) :261-266
[4]   NEUROPHARMACOLOGIC AND BEHAVIORAL ACTIONS OF CLONIDINE - INTERACTIONS WITH CENTRAL NEUROTRANSMITTERS [J].
BUCCAFUSCO, JJ .
INTERNATIONAL REVIEW OF NEUROBIOLOGY, 1992, 33 :55-107
[5]  
Budd DC, 1999, MOL PHARMACOL, V56, P813
[6]   Metabotropic glutamate 1α and adenosine A1 receptors assemble into functionally interacting complexes [J].
Ciruela, F ;
Escriche, M ;
Burgueño, J ;
Angulo, E ;
Casadó, V ;
Soloviev, MM ;
Canela, EI ;
Mallol, J ;
Chan, WY ;
Lluis, C ;
McIlhinney, RAJ ;
Franco, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18345-18351
[7]  
COTECCHIA S, 1990, J BIOL CHEM, V265, P63
[8]   The I-1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla [J].
Ernsberger, P ;
Haxhiu, MA .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 273 (05) :R1572-R1579
[9]  
ERNSBERGER P, 1990, J PHARMACOL EXP THER, V253, P408
[10]  
Ernsberger P, 1995, Ann N Y Acad Sci, V763, P22, DOI 10.1111/j.1749-6632.1995.tb32388.x